Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 10, 2022 08:00 ET | Source: AUM Biosciences

AUM Biosciences Enters into Collaboration with Roche for Clinical Development of AUM001 in Combination with anti-PD-L1 Therapy in Solid Tumor Indications

SINGAPORE and BETHESDA, MD, May 10, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company focused on discovering and developing novel targeted oncology therapies, today...
May 05, 2022 08:00 ET | Source: AUM Biosciences

AUM Biosciences Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate AUM001 in Combination with KEYTRUDA® (pembrolizumab) in Colorectal Cancer

SINGAPORE, May 05, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, today announced that it...
April 19, 2022 08:00 ET | Source: AUM Biosciences

AUM Biosciences and HANDOK Presented Phase 1 Data for AUM-601 at ESMO Targeted Anticancer Therapies Congress 2022

SINGAPORE and SEOUL, South Korea, April 19, 2022 (GLOBE NEWSWIRE) -- AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology...
April 19, 2022 08:00 ET | Source: AUM Biosciences

AUM Biosciences와 HANDOK, ESMO Targeted Anticancer Therapies Congress 2022에서 AUM-601에 대한 임상1상 데이터 공개

싱가포르/한국 서울, April 19, 2022 (GLOBE NEWSWIRE) -- 임상 단계 바이오테크 기업으로 항암 신약 치료제 발견 및 개발에 중점을 두고 있는 AUM Biosciences는 한국의 혁신 주도 제약 및 헬스케어 회사인 Handok Inc. [002390: KOSPI], CMG Pharmaceutical Co. Ltd....